Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Placebo-controlled Trial of Rosiglitazone for Treatment of Ulcerative Colitis

NCT00065065 is registered in ClinicalTrials.gov with James Lewis as lead sponsor.

NCT NCT00065065
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00065065 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Placebo-controlled Trial of Rosiglitazone for Treatment of Ulcerative Colitis
Lead sponsor
James Lewis
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2002
Completion date
January 31, 2008
Enrollment
105 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

inflammatory bowel disease, ulcerative colitis